Gain-of-function mutations in iRHOM2 underlie Tylosis with oesophageal cancer (TOC), characterized by palmoplantar thickening, upregulate K16 with robust downregulation of its type II keratin binding partner, K6. The gene discussed is KRT80; the disease is palmoplantar keratoderma-esophageal carcinoma syndrome.